These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 35705019)
1. Long Noncoding RNA Brain Cytoplasmic RNA 1 Induces Cisplatin-Resistance of Cervical Cancer Cells by Sponging MicroRNA-330-5p and Upregulating High-Mobility Group Box 3. Sun D; Cao R; Han L; Yu X; Wang H; Wang X; Chen X Gynecol Obstet Invest; 2022; 87(3-4):200-210. PubMed ID: 35705019 [TBL] [Abstract][Full Text] [Related]
2. miR-96-5p regulates cervical cancer cell resistance to cisplatin by inhibiting lncRNA TRIM52-AS1 and promoting IGF2BP2. Wu EY; Huang LP; Bao JH Kaohsiung J Med Sci; 2022 Dec; 38(12):1178-1189. PubMed ID: 36354205 [TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA SOX2-OT Knockdown Inhibits Proliferation and Metastasis of Prostate Cancer Cells Through Modulating the miR-452-5p/HMGB3 Axis and Inactivating Wnt/β-Catenin Pathway. Song X; Wang H; Wu J; Sun Y Cancer Biother Radiopharm; 2020 Nov; 35(9):682-695. PubMed ID: 32407168 [No Abstract] [Full Text] [Related]
4. Exosome-delivered circRNA circSYT15 contributes to cisplatin resistance in cervical cancer cells through the miR-503-5p/RSF1 axis. Chen Z; Xu Z; Wang Q; Wang L; Zhang H; Wang W; Zhao H; Guo Y; Cui J Cell Cycle; 2023 Oct; 22(20):2211-2228. PubMed ID: 37974391 [TBL] [Abstract][Full Text] [Related]
5. LncRNA NORAD/miR-202-5p regulates the drug resistance of A549/DDP to cisplatin by targeting P-gp. Shen JG; Xu SN; Yin LG Gen Physiol Biophys; 2020 Sep; 39(5):481-489. PubMed ID: 33084601 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA CASC2 enhances cisplatin sensitivity in oral squamous cell cancer cells by the miR-31-5p/KANK1 axis. Wang J; Jia J; Zhou L Neoplasma; 2020 Nov; 67(6):1279-1292. PubMed ID: 32787433 [TBL] [Abstract][Full Text] [Related]
7. Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1. Zhang Y; Ai H; Fan X; Chen S; Wang Y; Liu L Biol Res; 2020 Apr; 53(1):18. PubMed ID: 32349783 [TBL] [Abstract][Full Text] [Related]
8. LINC00857 promotes colorectal cancer progression by sponging miR-150-5p and upregulating HMGB3 (high mobility group box 3) expression. Zhou D; He S; Zhang D; Lv Z; Yu J; Li Q; Li M; Guo W; Qi F Bioengineered; 2021 Dec; 12(2):12107-12122. PubMed ID: 34753396 [TBL] [Abstract][Full Text] [Related]
9. CircRNA circ_0005273 contributes to the cisplatin resistance of cervical cancer cells by sponging miR-133b. Wu L; Gao J; Liu S; Jia Y; Li C; Duan L J Obstet Gynaecol; 2022 Oct; 42(7):3086-3093. PubMed ID: 35861544 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA GAS5 promotes cisplatin-chemosensitivity of osteosarcoma cells via microRNA-26b-5p/TP53INP1 axis. Li G; Yan X J Orthop Surg Res; 2023 Nov; 18(1):890. PubMed ID: 37993867 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA SNHG1 contributes to cisplatin resistance in non-small cell lung cancer by regulating miR-140-5p/Wnt/β-catenin pathway. Shi SL; Zhang ZH Neoplasma; 2019 Sep; 66(5):756-765. PubMed ID: 31288529 [TBL] [Abstract][Full Text] [Related]
12. Exosomal lncRNA HEIH promotes cisplatin resistance in tongue squamous cell carcinoma via targeting miR-3619-5p/HDGF axis. Wang X; Yu H; Yu Z; Wang D Acta Histochem; 2020 Dec; 122(8):151647. PubMed ID: 33130420 [TBL] [Abstract][Full Text] [Related]
13. LncRNA BCYRN1 inhibits glioma tumorigenesis by competitively binding with miR-619-5p to regulate CUEDC2 expression and the PTEN/AKT/p21 pathway. Mu M; Niu W; Zhang X; Hu S; Niu C Oncogene; 2020 Nov; 39(45):6879-6892. PubMed ID: 32978519 [TBL] [Abstract][Full Text] [Related]
14. miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs). Liu X; Zhou X; Chen Y; Huang Y; He J; Luo H Neoplasma; 2020 Jan; 67(1):147-157. PubMed ID: 31686523 [TBL] [Abstract][Full Text] [Related]
15. Hsa_circ_0074269-mediated Upregulation of TUFT1 Through miR-485-5p Increases Cisplatin Resistance in Cervical Cancer. Chen J; Wu S; Wang J; Sha Y; Ji Y Reprod Sci; 2022 Aug; 29(8):2236-2250. PubMed ID: 35075616 [TBL] [Abstract][Full Text] [Related]
16. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis. Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110 [TBL] [Abstract][Full Text] [Related]
17. linc00958/miR-185-5p/RSF-1 modulates cisplatin resistance and angiogenesis through AKT1/GSK3β/VEGFA pathway in cervical cancer. Tian J; Cheng L; Kong E; Gu W; Jiang Y; Hao Q; Kong B; Sun L Reprod Biol Endocrinol; 2022 Sep; 20(1):132. PubMed ID: 36056431 [TBL] [Abstract][Full Text] [Related]
18. HOTAIR mediates cisplatin resistance in nasopharyngeal carcinoma by regulating miR-106a-5p/SOX4 axis. Cao W; Sun Y; Liu L; Yu J; Ji J; Wang Y; Yang J Bioengineered; 2022 Mar; 13(3):6567-6578. PubMed ID: 35227173 [TBL] [Abstract][Full Text] [Related]
19. Linc00852 from cisplatin-resistant gastric cancer cell-derived exosomes regulates COMMD7 to promote cisplatin resistance of recipient cells through microRNA-514a-5p. Cao S; Fu B; Cai J; Zhang D; Wang C; Wu H Cell Biol Toxicol; 2023 Apr; 39(2):483-496. PubMed ID: 35088190 [TBL] [Abstract][Full Text] [Related]
20. LINC00460 knockdown sensitizes cervical cancer to cisplatin by downregulating TGFBI. Tian P; Feng Y; Tao L Chem Biol Drug Des; 2024 Jan; 103(1):e14424. PubMed ID: 38230774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]